High-Density Lipoprotein-Targeted Therapies - Not Dead Yet

Alvaro Garcia-Ropero; Carlos G. Santos-Gallego; Juan J. Badimon

doi:10.1001/jamacardio.2018.3962

High-Density Lipoprotein-Targeted Therapies - Not Dead Yet

Alvaro Garcia-Ropero, Carlos G. Santos-Gallego, Juan J. Badimon

Research output: Contribution to journal › Letter › peer-review

6 Scopus citations

Original language	English
Pages (from-to)	1254-1255
Number of pages	2
Journal	JAMA Cardiology
Volume	3
Issue number	12
DOIs	https://doi.org/10.1001/jamacardio.2018.3962
State	Published - Dec 2018

Access to Document

10.1001/jamacardio.2018.3962

Cite this

@article{3e055f1c601240c485527ec776aa2cc3,

title = "High-Density Lipoprotein-Targeted Therapies - Not Dead Yet",

author = "Alvaro Garcia-Ropero and Santos-Gallego, \{Carlos G.\} and Badimon, \{Juan J.\}",

note = "Funding Information: Conflict of Interest Disclosures: Dr Fordyce has received personal fees from Bayer, Novo Nordisk, Boehringer Ingelheim, and Sanofi as well as support from the Clinician Investigator Program, University of British Columbia. Dr Douglas has received research grants from GE Healthcare and HeartFlow. Dr Udelson has received grants from the National Heart, Lung, and Blood Institute.",

year = "2018",

month = dec,

doi = "10.1001/jamacardio.2018.3962",

language = "English",

volume = "3",

pages = "1254--1255",

journal = "JAMA Cardiology",

issn = "2380-6583",

publisher = "American Medical Association",

number = "12",

}

TY - JOUR

T1 - High-Density Lipoprotein-Targeted Therapies - Not Dead Yet

AU - Garcia-Ropero, Alvaro

AU - Santos-Gallego, Carlos G.

AU - Badimon, Juan J.

N1 - Funding Information: Conflict of Interest Disclosures: Dr Fordyce has received personal fees from Bayer, Novo Nordisk, Boehringer Ingelheim, and Sanofi as well as support from the Clinician Investigator Program, University of British Columbia. Dr Douglas has received research grants from GE Healthcare and HeartFlow. Dr Udelson has received grants from the National Heart, Lung, and Blood Institute.

PY - 2018/12

Y1 - 2018/12

UR - https://www.scopus.com/pages/publications/85057801003

U2 - 10.1001/jamacardio.2018.3962

DO - 10.1001/jamacardio.2018.3962

M3 - Letter

C2 - 30484828

AN - SCOPUS:85057801003

SN - 2380-6583

VL - 3

SP - 1254

EP - 1255

JO - JAMA Cardiology

JF - JAMA Cardiology

IS - 12

ER -